2-(cyclopropylmethyl)hexahydrocyclopenta[c]pyrrole-3a(1H)-carboxylic acid, 95.0%, 1g

(2S,3S)-2-((S)-2-(((Benzyloxy)carbonyl)amino)-4-methylpentanamido)-3-methylpentanoic acid, 98%, 100mg

2-Amino-5,6-dihydro-1,3-benzothiazol-7(4H)-one, 95.0%, 25g

(R)-3-(Pyrrolidin-2-yl)phenol hydrochloride, 95.0%, 500mg

Ácido 4-hidrazinabenzoico, mínimo 97 %, para síntesis, 10 g, envase de vidrio

2-Methylbenzo[d]oxazole, 95.0%, 25g

3-IODO-4-METHYL-1H-INDAZOLE, 95%, 5g

N-(2-sec-Butylphenyl)-2-chloropropanamide, 97%, 2g

METHYL 3-BROMO-1-METHYLINDAZOLE-6-CARBOXYLATE, 95.0%, 1g

1,2,5-Pentanetriol>97.0%(GC)5g

Fmoc-L-homoserine, 98%, 10g

4-Methyl-1,2,3-thiadiazole-5-methanol, 98.0%, 1g

Tert-butyl 3-(cyanomethyl)-3-hydroxyazetidine-1-carboxylate, 98%, 1g